Viewing data from:

CANGRELOR

ANDA

CANGRELOR | A213703 | MSN LABORATORIES PRIVATE LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: KENGREAL(TE code: AP)

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

VERANOVA LPCANGRELOR

DMF 184352005

OLON SPACANGRELOR TETRASODIUM

DMF 332952018

MSN LIFE SCIENCES PRIVATE LTDCANGRELOR TETRA SODIUM

DMF 333172018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 21, 2021	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 50MG/VIAL

0 patents0 exclusivities▴

POWDER;INTRAVENOUS | Approved: Jun 4, 2026

No patent or exclusivity listings for this strength.

Change History (1)

Recent changes detected for this application.

ADDED7/1/2026

Cangrelor (cangrelor) received FDA approval under NDA 213703 for indication 001.

New: New record